KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $51.2 million.

  • Emergent BioSolutions' Income from Continuing Operations fell 5540.07% to $51.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year increase of 13635.06%. This contributed to the annual value of -$190.6 million for FY2024, which is 7493.75% up from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Income from Continuing Operations is $51.2 million, which was down 5540.07% from -$12.0 million recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Income from Continuing Operations high stood at $177.9 million for Q4 2021, and its period low was -$283.1 million during Q2 2024.
  • For the 5-year period, Emergent BioSolutions' Income from Continuing Operations averaged around -$44.1 million, with its median value being -$31.3 million (2024).
  • In the last 5 years, Emergent BioSolutions' Income from Continuing Operations skyrocketed by 65760.0% in 2021 and then plummeted by 493243.24% in 2023.
  • Over the past 5 years, Emergent BioSolutions' Income from Continuing Operations (Quarter) stood at $177.9 million in 2021, then tumbled by 137.66% to -$67.0 million in 2022, then rose by 26.12% to -$49.5 million in 2023, then soared by 36.77% to -$31.3 million in 2024, then skyrocketed by 263.58% to $51.2 million in 2025.
  • Its last three reported values are $51.2 million in Q3 2025, -$12.0 million for Q2 2025, and $68.0 million during Q1 2025.